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Clinical trials are often designed to compare an ordinal
outcome such as New York Heart Association (NYHA)
functional classification or a non-Normal outcome such
as duration of hospital stay in cardiovascular trials. The
conventional statistical method for such a comparison is
a non-parametric Mann-Whitney test, which provides a
P-value for testing the hypothesis that the distributions
of both treatment groups are identical but does not pro-
vide an estimate of treatment effect. For that, Hodges
and Lehmann proposed estimating the shift parameter
between two populations and its confidence interval.
However, such a shift parameter does not have a
straightforward interpretation and its confidence interval
contains zero in some cases when Mann-Whitney test
produces significant result.
To overcome the above problems, we introduce the
concept of the win ratio for analysing such data. The ori-
ginal use of the win ratio was for a hierarchy of compo-
site time to event outcomes (Pocock et al 2012). Patients
in the new and control treatment are formed into all pos-
sible pairs. For each pair the new treatment patient is
labelled a “winner” or a “loser” if it is known who had a
favourable outcome. The win ratio is the total number of
winners divided by the total numbers of losers. A 95% CI
and P-value for the win ratio are readily obtained.
This method is demonstrated by analyses of NYHA in
PARTNER B trial and hospital stay in PLACIDE trial.
Statistical properties of the win ratio statistic are investi-
gated using simulation studies of non-Normal outcomes
under various scenarios.
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